# Albinterferon Alfa 2b Single Dose in Japanese Chronic Hepatitis C Patients

> **NCT00724776** · PHASE1 · COMPLETED · sponsor: **Novartis** · enrollment: 30 (actual)

## Conditions studied

- Chronic Hepatitis C

## Interventions

- **BIOLOGICAL:** Albinterferon alfa 2b

## Key facts

- **NCT ID:** NCT00724776
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2009-07
- **Final completion:** —
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2020-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00724776

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00724776, "Albinterferon Alfa 2b Single Dose in Japanese Chronic Hepatitis C Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00724776. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*